Biogenera achieved two milestones for its anti-tumor drug BGA002: completing GMP-grade active ingredient production and launching a research collaboration with the University of Chicago. Using PNA...
Innovative SME Biogenera successfully closes its third equity crowdfunding round on Crowdfundme with nearly $3.5 million (€3 million) and over 600 investors. Biogenera has conceived and...